Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic interaction study of antiretroviral therapy and chemotherapy in HIV-associated lymphoma
NL-OMON37346Active, not recruiting
- Sponsor
- OLVG
- Start
- Mar 2013
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of cyclophosphamide, etoposide, vinblastine and vincristine in lymphoma and human immunodeficiency virus infection (HIV), sponsored by OLVG. Primary endpoints: Pharmacokinetic exposure of antineoplastic drugs, Pharmacokinetic exposure of antiretroviral agents and 3 more. Started Mar 2013; status: active, not recruiting.
02
Drugs
cyclophosphamideetoposidevinblastinevincristine
03
Conditions
lymphomahuman immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NL-OMON37346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37346.